TNFSF18 and neoplasm: We further demonstrated that platelet-derived non-malignant MHC class I and platelet-derived GITRL (pGITRL) are transferred to tumor cells upon interaction with platelets, which impedes reactivity of NK cells via their cognate receptors [10, 11].